Warning: Undefined variable $subreddit_drop in /home3/thegood9/public_html/website_70aad9ea/functions.php on line 998

Warning: Undefined array key "thumbnail" in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 25
StackHealth / FDA grants early access to experimental pancreatic cancer drug

Vivek Subbiah: F.D.A. Grants Early Access to Promising Drug for Pancreatic Cancer

oncodaily - Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a post on LinkedIn: “Wow! It’s Big news on Friday. F.D.A. Grants Early Access to Promising Drug for […]

AI Summary: The FDA has authorized early access to a promising experimental therapy for pancreatic cancer, opening an expanded‑access pathway so eligible patients can receive the drug before full approval. Regulators based the decision on encouraging early clinical signals of activity and manageable safety data, aiming to offer options for a disease with few effective treatments—because pancreatic cancer isn’t known for its patience.

#healthcare #pharmaceuticals #biotech #drugdevelopment #fda #oncology #pancreaticcancer #cancerresearch #clinicaltrials

Daraxonrasib expanded access: FDA opens early pathway

FDA grants expanded access to the pancreatic cancer drug daraxonrasib

27 days / medicalxpress

Maen Abdelrahim: FDA Grants Expanded Access for Daraxonrasib in Pancreatic Cancer

27 days / oncodaily

Yannick Buccella: Historic Day for the GI Oncology Community

28 days / oncodaily

FDA Greenlit New Pancreatic Cancer Drug Daraxonrasib For Expanded Access

28 days / oncodaily

Vivek Subbiah: F.D.A. Grants Early Access to Promising Drug for Pancreatic Cancer

29 days / oncodaily

F.D.A. Grants Early Access to Promising Drug for Pancreatic Cancer

4 wks / nytimes / Rebecca Robbins and Gina Kolata


Research advances: diagnostics and targeted therapies for pancreatic cancer

Michael Chuong: 4-Year Success Using Ablative Radiation for Advanced Pancreatic Cancer

26 days / oncodaily

Anirban Maitra: Strong Showing from NYU Langone Health at the Pancreas Club Meeting in Chicago

26 days / oncodaily

Pancreatic ductal adenocarcinoma: integrating molecular insights for targeted interventions

27 days / nature

Blocking a cellular inflammation process could result in effective therapy for pancreatic cancer

28 days / medicalxpress

Microchip nanoparticle test spots pancreatic cancer in blood, outperforming biopsy in early trial

29 days / medicalxpress


All Other Stories

Phase 2 nITRO Trial: Perioperative NALIRIFOX in resectable PDAC

17 days / oncodaily

Daraxonrasib Shows Antitumour Activity Among Patients with Previously Treated RAS-mutated Pancreatic Ductal Adenocarcinoma

17 days / esmo

How an ‘Impossible’ Idea Led to a Pancreatic Cancer Breakthrough

19 days / nytimes / Gina Kolata and Rebecca Robbins

Dan Zhao: A New Article on Pancreatic Cancer

21 days / oncodaily

Daraxonrasib Shows Antitumor Activity in Previously Treated RAS-Mutated Pancreatic Cancer

22 days / oncodaily

Chadi Nabhan: Discussing Elraglusib Activity in Pancreatic Cancer With Deva Mahalingam

23 days / oncodaily

RAS(ON) inhibitor daraxonrasib shows promising results in advanced pancreatic cancer

24 days / medicalxpress

Pancreatic cancer drug extends survival 8.5 months: Study

24 days / beckershospitalreview / Elizabeth Gregerson

New AI model spots pancreatic cancer up to 3 years earlier than human doctors in test

24 days / livescience

Machine learning-based prognostic signature integrating mitochondrial function and programmed cell death patterns in pancreatic adenocarcinoma

25 days / nature

Ahmet Dirican: Pancreatic Cancer May Be Entering a New Era

25 days / oncodaily

Yan Leyfman: Redefining What’s Biologically Possible in Pancreatic Cancer

26 days / oncodaily

Pashtoon Kasi: FDA Expands Access to DaraxonRASib for Pancreatic Cancer

26 days / oncodaily

Yannick Neuder: Grenoble Alpes University Hospital Achieves a European First in the Fight Against Pancreatic Cancer

29 days / oncodaily

Back to Top / Saturday, May 2, 2026, 4:21 pm / permalink 23136 / 25 stories in 29 days /


Warning: Undefined variable $thumbnail in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 61


Related Stories


Warning: Undefined variable $top_stories in /home3/thegood9/public_html/website_70aad9ea/cluster.php on line 128

Daraxonrasib improves survival versus chemotherapy in metastatic pancreatic cancer / 3 hrs

VOLGA Phase III shows survival benefit for bladder cancer neoadjuvant combo / 15 days

New drug doubles one-year survival in metastatic pancreatic cancer / 6 wks

Datroway secures regulatory approvals in breast cancer across US and EU / 8 days

FDA clears first targeted therapy for ultra-rare NRG1-driven cholangiocarcinoma / 20 days

FDA approves relacorilant plus nab‑paclitaxel for resistant ovarian cancers / 7 wks

FDA flags misleading cancer drug claims tied to biotech billionaire / 2 months

StackHealth RSS

You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Vitamin D, Supply Chain, Nutrition, Health IT and look for the RSS link.


↑

NorthFeed Inc. Terms and Conditions / Privacy Policy

Disclaimer: The information provided on this website is intended for general informational purposes only. While we strive for accuracy, we do not guarantee the completeness or reliability of the content. Users are encouraged to verify all details independently. We accept no liability for errors, omissions, or any decisions made based on this information.